The Prognostic Implication of Inflammatory Factor-Based Scoring System in Diffuse Large B-Cell Lymphoma Patients in the Rituximab Era

被引：0
|
作者：
Lee, Ji Hyun
Oh, Sung Yong
Jo, Jae-Cheol
Choi, Yunsuk
Shin, Ho-Jin
Lee, Won-Sik
Kyung, Kwon A.
Lee, Yoojin
Lee, Ho Sup
机构：
来源：
BLOOD | 2017年 / 130卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4142
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Rebirth of radiotherapy for elderly patients with diffuse large B-cell lymphoma in the rituximab era
    Flowers, Christopher R.
    Cohen, Jonathon B.
    Khan, Mohammad K.
    LEUKEMIA & LYMPHOMA, 2015, 56 (03) : 557 - 558
  • [32] A Novel Inflammatory-Nutritional Prognostic Scoring System for Patients with Diffuse Large B Cell Lymphoma
    Wang, Zanzan
    Bao, Yurong
    Xu, Zhijuan
    Sun, Yongcheng
    Yan, Xiao
    Sheng, Lixia
    Ouyang, Guifang
    JOURNAL OF INFLAMMATION RESEARCH, 2024, 17 : 1 - 13
  • [33] THE HIGHEST PROGNOSTIC IMPACT OF LDH AMONG INTERNATIONAL PROGNOSTIC INDICES IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA IN THE RITUXIMAB ERA
    Park, J. H.
    Suh, C.
    Yoon, D. H.
    Kim, S. M.
    Kim, D. Y.
    Kim, S.
    Kim, J.
    Kim, K. A.
    Lee, S. W.
    Park, C.
    Huh, J.
    HAEMATOLOGICA, 2012, 97 : 128 - 128
  • [34] Prognostic implication of leucocyte subpopulations in diffuse large B-cell lymphoma
    Han, Xiao
    Ruan, Jing
    Zhang, Wei
    Zhou, Daobin
    Xu, Dongsheng
    Pei, Qiang
    Ouyang, Mingqi
    Zuo, Mengxuan
    ONCOTARGET, 2017, 8 (29) : 47790 - 47800
  • [35] Statin Use and Prognosis in Patients With Diffuse Large B-Cell Lymphoma and Follicular Lymphoma in the Rituximab Era
    Nowakowski, Grzegorz S.
    Maurer, Matthew J.
    Habermann, Thomas M.
    Ansell, Stephen M.
    Macon, William R.
    Ristow, Kay M.
    Allmer, Cristine
    Slager, Susan L.
    Witzig, Thomas E.
    Cerhan, James R.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (03) : 412 - 417
  • [36] PHARMACOKINETICS OF RITUXIMAB IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA
    Rozman, S.
    Grabnar, I.
    Novakovic, S.
    Mrhar, A.
    Novakovic, B. Jezersek
    HAEMATOLOGICA, 2017, 102 : 688 - 688
  • [37] Prognostic models for diffuse large B-cell lymphoma in the rituximab era: a never-ending story
    Bari, A.
    Marcheselli, L.
    Sacchi, S.
    Marcheselli, R.
    Pozzi, S.
    Ferri, P.
    Balleari, E.
    Musto, P.
    Neri, S.
    Spiriti, M. A. Aloe
    Cox, M. C.
    ANNALS OF ONCOLOGY, 2010, 21 (07) : 1486 - 1491
  • [38] Caspase 3a: new prognostic marker for diffuse large B-cell lymphoma in the rituximab era
    Provencio, Mariano
    Martin, Paloma
    Garcia, Vanesa
    Candia, Antonio
    Sanchez, Antonio C.
    Bellas, Carmen
    LEUKEMIA & LYMPHOMA, 2010, 51 (11) : 2021 - 2030
  • [39] Prognostic significance of serum beta-2 microglobulin in patients with diffuse large B-cell lymphoma in the rituximab era
    Seo, Seyoung
    Hong, Jung Yong
    Yoon, Shinkyo
    Yoo, Changhoon
    Park, Ji Hyun
    Lee, Jung Bok
    Park, Chan-Sik
    Huh, Jooryung
    Lee, Yoonse
    Kim, Kyung Won
    Ryu, Jin-Sook
    Kim, Seok Jin
    Kim, Won Seog
    Yoon, Dok Hyun
    Suh, Cheolwon
    ONCOTARGET, 2016, 7 (47) : 76934 - 76943
  • [40] Regarding "Hepatitis B Surface Antigen Positivity Is an Independent Unfavorable Prognostic Factor in Diffuse Large B-Cell Lymphoma in the Rituximab Era"
    Picardi, Marco
    Giordano, Claudia
    Della Pepa, Roberta
    Pugliese, Novella
    Leone, Aldo
    Delle Cave, Giuseppe
    Iula, Rossella
    Pane, Fabrizio
    Gentile, Giuseppe
    ONCOLOGIST, 2021, 26 (06): : E1083 - E1084
12345